The latest immunotherapy news and developments
Chimeric antigen receptor (CAR) T cell therapy, which uses engineered T cells to treat certain…
A retrospective analysis of large datasets of biomarkers from tumors and healthy tissue by researchers…
A clinical trial conducted at UNC Lineberger Comprehensive Cancer Center and Johns Hopkins Sidney Kimmel…
A new study from scientists at Emory Vaccine Center and Winship Cancer Institute of Emory…
After over a century of development, cancer immunotherapy (CIT) has risen to become a promising…
A specially designed lipid nanoparticle could deliver immune-signalling molecules into liver macrophage cells to overcome…
In recent years, immune-based treatments for cancer have buoyed the hopes of doctors and patients…
Artificial intelligence, along with a $71-million expansion of Radiation Oncology services, is allowing UT Southwestern…
Immunotherapy agents that inhibit the molecules PD1, PD-L1 or CTLA-4 have become widely used in…
Researchers at City of Hope, USA, looked at the most common type of metastatic colorectal…